Observational studyJournal of cardiovascular electrophysiology2026
A Comprehensive Assessment of Renal Function During and After Pulsed Field Ablation.
Observational study in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Comprehensive Assessment of Renal Function During and After Pulsed Field Ablation.Journal of cardiovascular electrophysiology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAcute kidney injury is an uncommon complication of pulsed field ablation (PFA). There is, however, limited empirical data on the dynamics of renal biomarkers apart from creatinine. Furthermore, no study to date has assessed creatinine at more than 24 h after the procedure.
methodsPatients undergoing PFA for atrial fibrillation (AF) were enrolled in a prospective observational study. The ablation was performed using the Farawave pentaspline catheter along with the Farapulse system and consisted of pulmonary vein isolation along with additive lesions in patients with persistent AF and/or atrial flutter. Administration of 500-1000 mL of crystalloid was a mandatory part of the periprocedural management protocol. Before and 24 h after the procedure, serum renal biomarkers were measured (urea, creatinine, cystatin C, NGAL, and KIM-1), and urinalysis was performed. Hemolysis indices (haptoglobin, Lactate Dehydrogenase, and red blood cell microparticles) were measured after the procedure. Patients were instructed to undergo blood sampling for creatinine and urea 48 h after the procedure.
resultsSamples from 88 patients were analyzed (mean age 67 ± 8.8 years, 33% female, 53% paroxysmal AF, average of 63 [IQR: 40-77] applied pulses). The creatinine concentration at 24 h decreased from 86 (IQR: 72-100) to 82 (IQR: 68-92) µmol/L (p < 0.001), the concentration at 48 h was similar to preprocedural values (83 [IQR: 69-100] µmol/L; (p = 1.00). However, 9 patients (10.2%) met AKI criteria; in six of them, AKI was only detectable at the 48-h measurement. Serum cystatin-C levels remained unchanged, and urea and urinary erythrocytes increase significantly from baseline to 24 h. NGAL levels increased significantly from 121 (IQR: 86-173) to 143 (IQR: 112-198) at 24 h while changes in KIM-1 were unsignificant. All changes in renal function were transient and did not require hospitalization. Logistic regression identified age and the total number of pulsed field pulses as the major risk factors for AKI.
conclusionsRoutine PFA with periprocedural hydration and an average of 63 PF pulses appears safe in patients without significant preexisting renal disease, with a low risk of clinically relevant renal impairment. However, the incidence of AKI in our cohort was higher than previously reported, suggesting that transient kidney function changes may be more common than recognized. These findings highlight the need for kidney function monitoring beyond 24 h in higher-risk patients undergoing PFA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.